Northern Trust Corp Buys 94,560 Shares of Xylem Inc. $XYL

Key Points

• Northern Trust Corp has increased its stake in Xylem Inc. by 2.9% in Q1, owning approximately 3.36 million shares worth $401.74 million.
• Several analysts have revised their target prices for Xylem, with UBS Group raising it to $168.00 and Stifel Nicolaus increasing it to $175.00 while maintaining a "buy" rating.
• Xylem has declared a quarterly dividend of $0.40 per share, with a yield of 1.1%, to be paid on September 25th to investors of record as of August 28th.

Northern Trust Corp lifted its position in Xylem Inc. (NYSE:XYL - Free Report) by 2.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,362,993 shares of the industrial products company's stock after acquiring an additional 94,560 shares during the quarter. Northern Trust Corp owned approximately 1.38% of Xylem worth $401,743,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Dynamic Advisor Solutions LLC bought a new position in Xylem during the first quarter valued at about $694,000. Farther Finance Advisors LLC grew its position in Xylem by 30.4% during the first quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock valued at $215,000 after buying an additional 419 shares during the period. NBC Securities Inc. purchased a new stake in Xylem in the 1st quarter worth about $72,000. Cambridge Investment Research Advisors Inc. increased its holdings in Xylem by 19.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 27,215 shares of the industrial products company's stock worth $3,251,000 after acquiring an additional 4,429 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in Xylem by 29.1% in the 1st quarter. GAMMA Investing LLC now owns 4,241 shares of the industrial products company's stock worth $507,000 after acquiring an additional 956 shares during the last quarter. Institutional investors own 87.96% of the company's stock.

Xylem Price Performance

Shares of XYL stock traded up $3.4010 on Friday, reaching $143.6210. The company's stock had a trading volume of 1,186,118 shares, compared to its average volume of 1,212,842. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $145.33. The company has a market capitalization of $34.96 billion, a P/E ratio of 37.30, a PEG ratio of 2.43 and a beta of 1.11. The stock's 50 day simple moving average is $134.27 and its 200-day simple moving average is $126.45.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter last year, the business posted $1.09 earnings per share. The firm's revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's dividend payout ratio (DPR) is 41.56%.

Analyst Upgrades and Downgrades

XYL has been the subject of several recent research reports. UBS Group lifted their price objective on Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a report on Tuesday, August 5th. JPMorgan Chase & Co. initiated coverage on Xylem in a report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective for the company. Citigroup reissued a "buy" rating and issued a $152.00 price objective (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Robert W. Baird decreased their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Finally, Raymond James Financial raised Xylem to a "hold" rating in a report on Thursday, May 15th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Xylem presently has a consensus rating of "Moderate Buy" and an average price target of $151.57.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.